DaVita (DVA) Tops Q1 EPS by 46c; Boosts outlook
Tweet
Share
E-mail
Get Alerts DVA Hot Sheet
Price: $182.09 -1.03%
Revenue Growth %: +2.6%
Financial Fact:
Patient care costs: 2.7B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +2.6%
Financial Fact:
Patient care costs: 2.7B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
DaVita (NYSE: DVA) reported Q1 EPS of $2.38, $0.46 better than the analyst estimate of $1.92. Revenue for the quarter came in at $3.07 billion versus the consensus estimate of $3.01 billion.
GUIDANCE:
DaVita sees FY2024 EPS of $9.00-$9.80, versus the consensus of $9.01.
For earnings history and earnings-related data on DaVita (DVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- Freeport-McMoRan shares surge as copper hits record $14,694/ton
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
